Neurosurgical Devices – Market Insights – United States
The US market for neurosurgical devices consists of a mixture of quickly expanding emerging technology markets and relatively mature market segments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurosurgical devices in the US across a 10-year period.
Expansion of neurosurgical device procedure volumes hinges on obtaining conclusive evidence demonstrating the comparative efficacy of these procedures over the current standard of care.
Which indications are most dynamic in terms of neurosurgery procedure penetration?
How will the use of novel neurosurgery devices affect neurosurgery procedure volumes?
ICH treatment is emerging as a new focus for neurosurgery that will see rapid growth upon release of positive clinical trial data.
What factors will drive adoption of surgical ICH procedures and devices tailored to those procedures?
How will increasing ICH treatment volumes affect the neurosurgery device market?
Neurosurgeons are reluctant to adopt new medical devices.
What factors will drive adoption of more recently launched novel neurosurgery devices?
How does this reluctance affect adoption of premium-priced next-generation devices?
In the US, neurosurgery devices have favorable reimbursement.
How does the reimbursement of neurosurgery devices in the US impact adoption rates?
How does reimbursement affect neurosurgery centers of excellence in the US?
Table of contents
- Neurosurgical Devices - Market Insights - United States
- Abstract
- Table of Contents
- List of Figures and Tables
- Neurosurgical Devices - United States - 2015
- Commentary (Karen Gierszewski)
- Executive Summary
- Version History
- Neurosurgical Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Neurosurgical Procedures, by Indication, US, 2013u20132023
- CSF Management Procedures, by Procedure Type, US, 2013u20132023
- Intracranial Hemorrhage Procedures, by Procedure Type, US, 2013u20132023
- Other Neurosurgery Procedures, by Procedure Type, US, 2013u20132023
- Neurosurgical Device Market, by Product Type, US (USD), 2013u20132023
- Neurosurgical Device Market Growth, by Product Type, USu200b, 2014u20132023
- General Market Trends
- Competitive Highlights
- Competitive Landscape
- Market Shares
- Market Factors and Developments
- Cerebrospinal Fluid Management Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CSF Management Device Market, by Product Type, US (USD), 2013u20132023
- CSF Management Device Market Growth, by Product Type, US, 2014u20132023
- Hydrocephalus Shunt Procedures, by Product Type, US, 2013u20132023
- Hydrocephalus Shunt Market, by Product Type, US (USD), 2013u20132023
- Hydrocephalus Shunt Market Growth, by Product Type, US, 2014u20132023
- ICP Monitoring Procedures, by Product Type, US, 2013u20132023
- EVD Device Market, by Product Type, US (USD), 2013u20132023
- EVD Device Market Growth, by Product Type, US, 2014u20132023
- Ventricular Catheter Procedures, by Product Feature, US, 2013u20132023
- Ventricular Catheter Market, by Product Feature, US (USD), 2013u20132023
- Ventricular Catheter Market Growth, by Product Feature, US, 2014u20132023
- Neuromonitoring Device Procedures, by Product Type, US, 2013u20132023
- Neuromonitoring Device Market, by Product Type, US (USD), 2013u20132023
- Neuromonitoring Device Market Growth, by Product Type, US, 2014u20132023
- General Market Trends
- Competitive Highlights
- Market Shares
- Neurosurgical Evacuation Device Market
- Neurosurgical Access Device Market
- Neurovascular Clip Market
- Neuroendoscopy Device Market
- Methodology
- Appendix
- Acronyms and Initialisms
- Bibliography
Ashish Bhupal is a senior manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor’s in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution.
Follow Ashish on Twitter: @Ashishb_DRG.